ClinicalTrials.gg
CompletedNCT04126889Updated Oct 15, 2019

Awareness and Knowledge of the Surgical Safety Checklist Among Operational Staff in University Teaching Hospital, Kathmandu, Nepal: A Cross-sectional Questionnaire

An observational study in Surgical Checklist, sponsored by Fukushima Medical University. Completed at 1 site in Nepal. Open to participants aged 24 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-15.

Sponsored by Fukushima Medical University · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
150
Ages
24 Years to 55 Years
Sex
All
01

Study summary

The introduction of the World Health Organization Surgical Safety Checklist (WHO SSC) is a priority to promote surgical safety. However, little is known regarding awareness and knowledge of the WHO SSC in developing countries. This study aimed to obtain region-specific information for the introduction of the checklist in a core medical institution in Nepal.

The present research was a cross-sectional study using data from a survey conducted at the Tribhuvan University Teaching Hospital (TUTH) in Kathmandu, Nepal. A questionnaire was distributed to 150 healthcare professionals working in the operating theatre. Responses to the questionnaire were analysed descriptively and regression analyses identified factors associated with awareness of the checklist.

02

Conditions studied

  • Surgical Checklist
03

In context

Lead sponsor

Fukushima Medical University is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

health professionals in operation room

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • have optimal experience

Exclusion criteria

Exclusion Criteria:

  • less experience
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
150 participants (actual)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • Otherquestionnaire survey

    questionnaire survey

06

What researchers measure

Primary outcomes

  1. Awareness of Surgical Safety Checklist

    Whether medical staffs know about Surgical Safety Checklist, Participants can answer to the question for yes or no.

    Time frame: 24 weeks

07

Study locations

1 site
  • Tribhuvan University Teaching Hospital
    Kathmandu, Nepal
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2018 to primary completion in Jun 2019, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 10, 2019
First posted
Oct 15, 2019
StartActual
Sep 1, 2018
Primary completionActual
Jun 1, 2019
CompletionActual
Oct 1, 2019
Last update
Oct 15, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04126889
Lead sponsor
Fukushima Medical University
Responsible party
Yurie Kobashi (Principal Investigator, Fukushima Medical University) — Principal investigator
First posted
Oct 15, 2019
Start date
Sep 1, 2018
Primary completion
Jun 1, 2019
Completion
Oct 1, 2019
Last update
Oct 15, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion